GXB: Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage

Gene
Study
Sample
Downloads

Full Name	--
Summary	--
Links
Pubmed Articles	--
User Notes	--

Description

Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage -

GSE22490

Purpose

INTRODUCTION:Recurrent miscarriage (RM; ?3 consecutive pregnancy losses) occurs in 1-3% of fertile couples. No biomarkers with high predictive value of threatening miscarriage have been identified. We aimed to profile whole-genome differential gene expression in RM placental tissue, and to determine the protein levels of identified loci in maternal sera in early pregnancy.METHODS:GeneChips (Affymetrix(®)) were used for discovery and Taqman RT-qPCR assays for replication of mRNA expression in placentas from RM cases (n = 13) compared to uncomplicated pregnancies matched for gestational age (n = 23). Concentrations of soluble TRAIL (sTRAIL) and calprotectin in maternal serum in normal first trimester (n = 35) and failed pregnancies (early miscarriage, n = 18, late miscarriage, n = 4; tubal pregnancy, n = 11) were determined using ELISA.RESULTS:In RM placentas 30 differentially expressed (with nominal P-value < 0.05) transcripts were identified. Significantly increased placental mRNA expression of TNF-related apoptosis-inducing ligand (TRAIL; P = 1.4 × 10(-3); fold-change 1.68) and S100A8 (P = 7.9 × 10(-4); fold-change 2.56) encoding for inflammatory marker calprotectin (S100A8/A9) was confirmed by RT-qPCR. When compared to normal first trimester pregnancy (sTRAIL 16.1 ± 1.6 pg/ml), significantly higher maternal serum concentration of sTRAIL was detected at the RM event (33.6 ± 4.3 pg/ml, P = 0.00027), and in pregnant women, who developed an unpredicted miscarriage 2-50 days after prospective serum sampling (28.5 ± 4.4 pg/ml, P = 0.039). Women with tubal pregnancy also exhibited elevated sTRAIL (30.5 ± 3.9 pg/ml, P = 0.035). Maternal serum levels of calprotectin were neither diagnostic nor prognostic to early pregnancy failures (P > 0.05).CONCLUSIONS:The study indicated of sTRAIL as a potential predictive biomarker in maternal serum for early pregnancy complications.

Experimental Design

10 gene arrays, 6 in control group and 4 in cases

Platform

Affymetrix HG-U133_Plus_2

No information available.

Default files:

Signal Data File

Download Annotations for Group Set:

Download Annotations for Group:

Download Ranklist:

Additional Files:

(Uploaded through the Files tab in the Annotation Tool)

sampleset4000031_sampleannotations_group.csv

SIDRA

GXB

Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage - GSE22490

Default files:

Additional Files:

Email Link

Copy Link

Change Rank List

Chart Options

No signal data found for this sample set.

Send a Bug Report

Add a New Note

Info Browser